COHEN RAYMOND W Insider Trading
Get the latest insider transactions of COHEN RAYMOND W. COHEN RAYMOND W is Director in BIOLIFE SOLUTIONS INC ($BLFS) and CEO in CARDIAC SCIENCE INC ($DFIB) and Chairman and CEO in CARDIAC SCIENCE INC ($DFIB) and Director in SPECTRUM PHARMACEUTICALS INC ($SPPI) and Chief Executive Officer in Axonics Modulation Technologies, Inc. ($AXNX). Discover the current value of COHEN RAYMOND W shares.
Address: 1900 MAIN STREET SUITE 700 IRVINE 92614CA
COHEN RAYMOND W is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| DFIB | CARDIAC SCIENCE INC | Chairman and CEO, CEO | 0 | 0.00 |
| BLFS | BIOLIFE SOLUTIONS INC | Director | 22,763 | 40,518.14 |
| SPPI | SPECTRUM PHARMACEUTICALS INC | Director | 53,850 | 267,096.00 |
| AXNX | Axonics, Inc. | Chief Executive Officer | 284,607 |
Insider Trading Transactions of COHEN RAYMOND W
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 60.00 | 33,333 | 1,999,980 | 284,607 |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 52.98 | 13,109 | 694,536 | 371,497 |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 54.13 | 17,954 | 971,798 | 353,543 |
| May 12 2021 | AXNX | Axonics, Inc. | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 54.81 | 2,770 | 151,824 | 350,773 |
| Feb 02 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 0.00 | 20,000 | 0 | 436,389 |
| Feb 02 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 0.00 | 33,334 | 0 | 469,723 |
| Feb 02 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 51.36 | 12,675 | 651,045 | 457,048 |
| Feb 02 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 52.12 | 952 | 49,616 | 456,096 |
| Feb 02 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 20,000 | 0 | 20,000 |
| Feb 02 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 42,500 | 0 | 42,500 |
| Feb 02 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 16,667 | 0 | 0 |
| Jan 27 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 0.00 | 27,173 | 0 | 424,231 |
| Jan 27 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 53.58 | 7,842 | 420,148 | 416,389 |
| Jan 27 2021 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 27,173 | 0 | 0 |
| Nov 16 2020 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 32.45 | 5,625 | 182,531 | 22,763 |
| Nov 16 2020 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 32.45 | 5,625 | 182,531 | 22,763 |
| Aug 11 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 41.82 | 16,633 | 695,659 | 425,425 |
| Aug 11 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 42.75 | 3,367 | 143,924 | 422,058 |
| Aug 11 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 40.95 | 5,159 | 211,282 | 416,899 |
| Aug 11 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 42.05 | 8,808 | 370,406 | 408,091 |
| Aug 11 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 42.78 | 11,033 | 471,948 | 397,058 |
| Jul 17 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 38.55 | 8,628 | 332,579 | 483,430 |
| Jul 17 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 39.61 | 15,472 | 612,804 | 467,958 |
| Jul 17 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 39.94 | 900 | 35,943 | 467,058 |
| Jul 17 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 39.65 | 25,000 | 991,268 | 442,058 |
| Jul 15 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 40.34 | 24,800 | 1,000,541 | 517,258 |
| Jul 15 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 41.10 | 200 | 8,220 | 517,058 |
| Jul 15 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 36.49 | 25,000 | 912,273 | 492,058 |
| Jul 15 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 40.34 | 24,800 | 1,000,541 | 517,258 |
| Jul 15 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 41.10 | 200 | 8,220 | 517,058 |
| Jul 15 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 36.49 | 25,000 | 912,273 | 492,058 |
| Mar 18 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 1.63 | 41,224 | 67,195 | 583,282 |
| Mar 18 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 20.87 | 34,269 | 715,249 | 549,013 |
| Mar 18 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 21.48 | 6,955 | 149,390 | 542,058 |
| Mar 18 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 1.63 | 41,224 | 67,195 | 106,776 |
| Feb 18 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 1.63 | 10,000 | 16,300 | 552,058 |
| Feb 18 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 33.21 | 10,000 | 332,065 | 542,058 |
| Feb 18 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 1.63 | 10,000 | 16,300 | 148,000 |
| Feb 03 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 0.00 | 16,667 | 0 | 625,058 |
| Feb 03 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 0.00 | 16,667 | 0 | 625,058 |
| Feb 03 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 16,667 | 0 | 0 |
| Feb 03 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 16,667 | 0 | 0 |
| Jan 16 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 1.63 | 10,000 | 16,300 | 618,391 |
| Jan 16 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 31.98 | 10,000 | 319,800 | 608,391 |
| Jan 16 2020 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 1.63 | 10,000 | 16,300 | 158,000 |
| Dec 16 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 27,173 | 0 | 27,173 |
| Dec 16 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 27,173 | 0 | 27,173 |
| Dec 16 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 25.82 | 78,125 | 2,017,188 | 78,125 |
| Nov 21 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Sell | 20.74 | 75,000 | 1,555,125 | 608,391 |
| Aug 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 1.12 | 5,357 | 6,000 | 28,745 |
| Aug 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 17.98 | 5,357 | 96,319 | 23,388 |
| Aug 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.12 | 5,357 | 6,000 | 0 |
| Aug 06 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 30.41 | 3,500 | 106,439 | 683,391 |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 1.12 | 5,357 | 6,000 | 28,745 |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 1.12 | 5,357 | 6,000 | 28,745 |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 16.57 | 5,357 | 88,765 | 23,388 |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 16.57 | 5,357 | 88,765 | 23,388 |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.12 | 5,357 | 6,000 | 0 |
| Jul 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.12 | 5,357 | 6,000 | 0 |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 0.00 | 10,000 | 0 | 53,850 |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Option Exercise | 8.44 | 20,000 | 168,800 | 20,000 |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 0.00 | 10,000 | 0 | 53,850 |
| Jun 21 2019 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Option Exercise | 8.44 | 20,000 | 168,800 | 20,000 |
| Jun 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 1.40 | 5,357 | 7,500 | 28,745 |
| Jun 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 17.48 | 5,357 | 93,640 | 23,388 |
| Jun 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.40 | 5,357 | 7,500 | 0 |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 1.90 | 10,000 | 19,000 | 48,388 |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 16.98 | 10,000 | 169,800 | 38,388 |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 17.99 | 15,000 | 269,850 | 23,388 |
| May 17 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.90 | 10,000 | 19,000 | 0 |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 2.06 | 15,000 | 30,900 | 53,388 |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 17.03 | 15,000 | 255,450 | 38,388 |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 2.06 | 15,000 | 30,900 | 0 |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 2.06 | 15,000 | 30,900 | 53,388 |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 17.03 | 15,000 | 255,450 | 38,388 |
| Apr 19 2019 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 2.06 | 15,000 | 30,900 | 0 |
| Mar 18 2019 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 9.59 | 5,000 | 47,950 | 43,850 |
| Feb 04 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 14.19 | 222,222 | 3,153,330 | 222,222 |
| Feb 04 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 16,667 | 0 | 16,667 |
| Feb 04 2019 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 16,667 | 0 | 16,667 |
| Dec 26 2018 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 1.26 | 5,357 | 6,755 | 38,388 |
| Dec 26 2018 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.26 | 5,357 | 6,755 | 0 |
| Nov 02 2018 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Buy | 0.00 | 8,760 | 0 | 688,651 |
| Nov 02 2018 | AXNX | Axonics Modulation Techno ... | COHEN RAYMOND W | Chief Executive Offic ... | Option Exercise | 0.00 | 7,300 | 0 | 0 |
| Aug 22 2018 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 23.68 | 10,000 | 236,800 | 33,031 |
| Aug 14 2018 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 19.70 | 10,000 | 197,000 | 43,031 |
| Jun 19 2018 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 0.00 | 10,000 | 0 | 38,850 |
| Jun 19 2018 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Option Exercise | 19.95 | 20,000 | 399,000 | 20,000 |
| Jun 01 2018 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Sell | 10.15 | 10,000 | 101,500 | 53,031 |
| May 15 2018 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Sell | 18.32 | 9,275 | 169,918 | 28,850 |
| Jan 03 2018 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 0.00 | 15,000 | 0 | 62,531 |
| Jan 03 2018 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 0.00 | 3,125 | 0 | 65,656 |
| Oct 03 2017 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 0.00 | 3,325 | 0 | 58,068 |
| Jul 07 2017 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 0.00 | 7,845 | 0 | 54,743 |
| Jun 29 2017 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Sell | 7.54 | 625 | 4,713 | 43,125 |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Sell | 6.48 | 2,500 | 16,200 | 33,750 |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Sell | 6.48 | 2,500 | 16,200 | 33,750 |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 0.00 | 10,000 | 0 | 43,750 |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 0.00 | 10,000 | 0 | 43,750 |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Option Exercise | 6.48 | 20,000 | 129,600 | 20,000 |
| Jun 15 2017 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Option Exercise | 6.48 | 20,000 | 129,600 | 20,000 |
| Apr 06 2017 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 0.00 | 8,929 | 0 | 46,898 |
| Feb 09 2017 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 1.12 | 17,857 | 20,000 | 37,969 |
| Feb 09 2017 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.12 | 17,857 | 20,000 | 0 |
| Jan 18 2017 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Buy | 0.00 | 11,646 | 0 | 20,112 |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Sell | 6.47 | 625 | 4,044 | 28,750 |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Sell | 6.33 | 2,500 | 15,825 | 26,250 |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 0.00 | 10,000 | 0 | 36,250 |
| Jun 29 2016 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Option Exercise | 6.33 | 20,000 | 126,600 | 20,000 |
| Mar 17 2016 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 1.90 | 10,000 | 19,000 | 10,000 |
| Jul 08 2015 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Sell | 6.96 | 625 | 4,350 | 29,375 |
| Jul 01 2015 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Buy | 0.00 | 10,000 | 0 | 30,000 |
| Jul 01 2015 | SPPI | SPECTRUM PHARMACEUTICALS ... | COHEN RAYMOND W | Director | Option Exercise | 6.96 | 20,000 | 139,200 | 20,000 |
| May 06 2015 | BLFS | BIOLIFE SOLUTIONS INC | COHEN RAYMOND W | Director | Option Exercise | 2.06 | 15,000 | 30,900 | 15,000 |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | Chairman and CEO | Sell | 0.00 | 128,253 | 0 | 0 |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | Chairman and CEO | Option Exercise | 3.99 | 350,000 | 1,396,500 | 0 |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | Chairman and CEO | Option Exercise | 2.00 | 50,000 | 100,000 | 0 |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | Chairman and CEO | Option Exercise | 4.00 | 150,000 | 600,000 | 0 |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | Chairman and CEO | Option Exercise | 1.75 | 300,000 | 525,000 | 0 |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | Chairman and CEO | Option Exercise | 2.06 | 1,600,000 | 3,296,000 | 0 |
| Sep 01 2005 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | Chairman and CEO | Option Exercise | 2.00 | 100,000 | 200,000 | 0 |
| Nov 12 2004 | DFIB | CARDIAC SCIENCE INC | COHEN RAYMOND W | CEO | Sell | 2.12 | 277,682 | 588,686 | 128,253 |